UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes Journal article
JOURNAL OF PSYCHOPHARMACOLOGY, 2019,Volume: 33,Issue: 10,Page: 1227-1236
Authors:  Zhang Cheng;  Yanbo Yuan;  Xue Han;  Shangli Cai;  Fude Yang;  Zheng Lu;  Chuanyue Wang;  Hong Deng;  Jingping Zhao;  Yutao Xiang;  Christoph U Correll;  Xin Yu
Favorite |  | TC[WOS]:5 TC[Scopus]:8 | Submit date:2020/05/26
First-episode  Schizophrenia  Antipsychotic  Efficacy  Safety  
Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial Journal article
Psychiatry Research, 2019,Volume: 273,Page: 631-640
Authors:  Cheng Zhang;  Yuan Yanbo;  Han Xue;  Yang Lei;  Zeng Xin;  Yang Fude;  Lu Zheng;  Wang Chuanyue;  Deng Hong;  Zhao Jingping;  Xiang Yu-Tao;  Christoph U. Correll;  Yu Xin
Favorite |  | TC[WOS]:4 TC[Scopus]:3 | Submit date:2020/09/25
First-episode  Antipsychotic  Discontinuation  Predictors  Schizophrenia  
Efficacy of atypical antipsychotics in the management of acute agitation and aggression in hospitalized patients with schizophrenia or bipolar disorder: results from a systematic review Journal article
Shanghai Archives of Psychiatry, 2016,Volume: 28,Issue: 5,Page: 241-252
Authors:  Yu,Xin;  Correll,Christoph U.;  Xiang,Yu Tao;  Xu,Yifeng;  Huang,Jizhong;  Yang,Fude;  Wang,Gang;  Si,Tianmei;  Kane,John M.;  Masand,Prakash
Favorite |  | TC[WOS]:0 TC[Scopus]:7 | Submit date:2021/03/02
Aggression  Agitation  Antipsychotic  Bipolar disorder  Schizophrenia